|
1
|
Ferragut Cardoso AP, Banerjee M, Nail AN,
Lykoudi A and States JC: miRNA dysregulation is an emerging
modulator of genomic instability. Semin Cancer Biol. 76:120–131.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Sousa MC, Gjorgjieva M, Dolicka D,
Sobolewski C and Foti M: Deciphering miRNAs' action through miRNA
editing. Int J Mol Sci. 20:62492019. View Article : Google Scholar
|
|
3
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Cheng L, Gao C, Chen J, Liao S,
Zheng Y, Xu L, He J, Wang D, Fang Z, et al: Androgen signaling
contributes to sex differences in cancer by inhibiting NF-κB
activation in T cells and suppressing antitumor immunity. Cancer
Res. 83:906–921. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He C, Wang X, Du M and Dong Y: LncRNA
MSC-AS1 promotes colorectal cancer progression by regulating
miR-325/TRIM14 axis. J Oncol. 2021:99542142021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun S, Liu F, Xian S and Cai D: miR-325-3p
overexpression inhibits proliferation and metastasis of bladder
cancer cells by regulating MT3. Med Sci Monit. 26:e9203312020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gan H, Lin L, Hu N, Yang Y, Gao Y, Pei Y,
Chen K and Sun B: KIF2C exerts an oncogenic role in nonsmall cell
lung cancer and is negatively regulated by miR-325-3p. Cell Biochem
Funct. 37:424–431. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Chen H, Song Y, Gu Q, Zhang L,
Xie Q, Xu J and Zhang M: MiR-325 promotes oxaliplatin-induced
cytotoxicity against colorectal cancer through the
HSPA12B/PI3K/AKT/Bcl-2 pathway. Dig Dis Sci. 66:2651–2660. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun T, Li K, Zhu K, Yan R, Dang C and Yuan
D: SNHG6 interacted with miR-325-3p to regulate cisplatin
resistance of gastric cancer by targeting GITR. Onco Targets Ther.
13:12181–12193. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang M, Chen X, Fu G and Ge M: Glutathione
peroxidase 2 overexpression promotes malignant progression and
cisplatin resistance of KRAS-mutated lung cancer cells. Oncol Rep.
48:2072022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li R, Xu T, Wang H, Wu N, Liu F, Jia X, Mi
J, Lv J and Gao H: Dysregulation of the miR-325-3p/DPAGT1 axis
supports HBV-positive HCC chemoresistance. Biochem Biophys Res
Commun. 519:358–365. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H, Huang W and Luo R: The microRNA-325
inhibits hepatocellular carcinoma progression by targeting high
mobility group box 1. Diagn Pathol. 10:1172015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li C, Zhang Y, Xie X, Lu X, Zhang S, Wang
Z, Chen X, Xiaoyu X, Xingchen L, Sen Z, Ziming W and Xianming C:
miR-325-3p, a novel regulator of osteoclastogenesis in osteolysis
of colorectal cancer through targeting S100A4. Mol Med. 27:232021.
View Article : Google Scholar
|
|
14
|
Huang Z, Luo Y, Chen C, Zhou C, Su Z, Cai
C, Li X and Wu W: miR-325-3p reduces proliferation and promotes
apoptosis of gastric cancer cells by inhibiting human antigen R.
Can J Gastroenterol Hepatol. 2023:68828512023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Ji Y, Chen YC and Zhen ZJ:
MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis
in hepatocellular carcinoma. Cytokine. 141:1554362021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Han Y, Sun G, Liu X, Jia X and Yu
X: MicroRNA-325-3p inhibits cell proliferation and induces
apoptosis in hepatitis B virus-related hepatocellular carcinoma by
down-regulation of aquaporin 5. Cell Mol Biol Lett. 24:132019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin T, Zhou S, Gao H, Li Y and Sun L:
MicroRNA-325 is a potential biomarker and tumor regulator in human
bladder cancer. Technol Cancer Res Treat. 17:15330338187905362018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li R, Zheng JZ and Huang X: Suppression of
HAX-1 induced by miR-325 resensitizes bladder cancer cells to
cisplatin-induced apoptosis. Eur Rev Med Pharmacol Sci.
24:9303–9314. 2020.PubMed/NCBI
|
|
19
|
Yao S, Zhao T and Jin H: Expression of
MicroRNA-325-3p and its potential functions by targeting HMGB1 in
non-small cell lung cancer. Biomed Pharmacother. 70:72–79. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Li Z, Liang J, Liu J, Hao J, Wan
Q, Liu J, Luo C and Lu Z: CircRNA has_circ_0069313 induced OSCC
immunity escape by miR-325-3p-Foxp3 axes in both OSCC cells and
Treg cells. Aging (Albany NY). 14:4376–4389. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xin CH and Li Z: LncRNA PWRN2 stimulates
the proliferation and migration in papillary thyroid carcinoma
through the miR-325/DDX5 axis. Eur Rev Med Pharmacol Sci.
24:10022–10027. 2020.PubMed/NCBI
|
|
22
|
Xiong Q and Su H: MiR-325-3p functions as
a suppressor miRNA and inhibits the proliferation and metastasis of
glioma through targeting FOXM1. J Integr Neurosci. 20:1019–1028.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu D, Gong H, Tao Z, Chen S, Kong Y and
Xiao B: LINC01515 promotes nasopharyngeal carcinoma progression by
serving as a sponge for miR-325 to up-regulate CDCA5. J Mol Histol.
52:577–587. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Hu X, Yang F and Xiao H:
miR-325-3p promotes the proliferation, invasion, and emt of breast
cancer cells by directly targeting S100A2. Oncol Res. 28:731–744.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Y, Liu Y, Ma X and Hu H: The influence
of cell cycle regulation on chemotherapy. Int J Mol Sci.
22:69232021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morana O, Wood W and Gregory CD: The
apoptosis paradox in cancer. Int J Mol Sci. 23:13282022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun S, Liu F, Xian S and Cai D: miR-325-3p
overexpression inhibits proliferation and metastasis of bladder
cancer cells by regulating MT3. Med Sci Monit. 26:e9203312020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen X, Gao J, Yu Y, Zhao Z and Pan Y:
LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of
cutaneous malignant melanoma via regulating miR-325/MAP3K2. Biomed
Pharmacother. 120:1094382019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Xu H, Li X, Zhang R, Bai J and
Zhang X: MicroRNA-325 targets lipocalin 15 to suppress
proliferation, migration and invasion of breast cancer cells. Arch
Med Sci. 19:1099–1107. 2023.PubMed/NCBI
|
|
30
|
Lambert AW and Weinberg RA: Linking EMT
programmes to normal and neoplastic epithelial stem cells. Nat Rev
Cancer. 21:325–338. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han T, Kang D, Ji D, Wang X, Zhan W, Fu M,
Xin HB and Wang JB: How does cancer cell metabolism affect tumor
migration and invasion? Cell Adh Migr. 7:395–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ouyang X, Feng L, Liu G, Yao L, Wang Z,
Liu S, Xiao Y and Zhang G: Androgen receptor (AR) decreases HCC
cells migration and invasion via miR-325/ACP5 signaling. J Cancer.
12:1915–1925. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ and
Xu RH: Circular RNA: Metabolism, functions and interactions with
proteins. Mol Cancer. 19:1722020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Karagkouni D, Karavangeli A,
Paraskevopoulou MD and Hatzigeorgiou AG: Characterizing
miRNA-lncRNA interplay. Methods Mol Biol. 2372:243–262. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu Q, Yang Z, Nie Y, Shi Y and Fan D:
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and
lab approaches. Cancer Lett. 347:159–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
